Related references
Note: Only part of the references are listed.High-Throughput immunogenetics for precision medicine in cancer
Andreas Agathangelidis et al.
SEMINARS IN CANCER BIOLOGY (2022)
Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
Francesca Perutelli et al.
FRONTIERS IN ONCOLOGY (2022)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines
William G. Wierda et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia
Alessandra Rovida et al.
CLINICAL CANCER RESEARCH (2021)
Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications
Paul J. Hengeveld et al.
EXPERIMENTAL HEMATOLOGY (2021)
The Clonotypic BCR IG of CLL Patients Contain Predicted T-Cell Class I Epitopes with Shared Structural Properties
Anna Vardi et al.
BLOOD (2021)
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
Elisavet Vlachonikola et al.
FRONTIERS IN IMMUNOLOGY (2021)
The good, the bad, and the ugly: Evolutionary and pathological aspects of gene dosage alterations
M. Felicia Basilicata et al.
PLOS GENETICS (2021)
TAP 1.0: A robust immunoinformatic tool for the prediction of tumor T-cell antigens based on AAindex properties
Jesus Herrera-Bravo et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2021)
T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
Elisavet Vlachonikola et al.
CANCERS (2021)
CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism
Matteo Grioni et al.
BLOOD ADVANCES (2021)
VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium
Dmitry Bagaev et al.
NUCLEIC ACIDS RESEARCH (2020)
High-throughput analysis of the T-cell receptor gene repertoire in low-count monoclonal B-cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia
Andreas Agathangelidis et al.
HAEMATOLOGICA (2020)
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions
Francesca Arruga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2020)
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities
Anna Vardi et al.
CLINICAL CANCER RESEARCH (2020)
TRIP - T cell receptor/immunoglobulin profiler
Maria Th. Kotouza et al.
BMC BIOINFORMATICS (2020)
Treatment of Chronic Lymphocytic Leukemia
Jan A. Burger
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prediction of Specific TCR-Peptide Binding From Large Dictionaries of TCR-Peptide Pairs
Ido Springer et al.
FRONTIERS IN IMMUNOLOGY (2020)
A guide to the application of Hill numbers to DNA-based diversity analyses
Antton Alberdi et al.
MOLECULAR ECOLOGY RESOURCES (2019)
Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements
A. Vardi et al.
LEUKEMIA (2017)
Aging-related changes in human T-cell repertoire over 20 years delineated by deep sequencing of peripheral T-cell receptors
Kengo Yoshida et al.
EXPERIMENTAL GERONTOLOGY (2017)
Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors
Semeli Mastrodemou et al.
LEUKEMIA & LYMPHOMA (2017)
Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons
Ana E. Rodriguez-Vicente et al.
ONCOTARGET (2017)
Antigen Selection Shapes the T-cell Repertoire in Chronic Lymphocytic Leukemia
Anna Vardi et al.
CLINICAL CANCER RESEARCH (2016)
Tumor microenvironment (TME)-driven immune suppression in B cell malignancy
Nicole S. Nicholas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Robust estimates of overall immune-repertoire diversity from high-throughput measurements on samples
Joseph Kaplinsky et al.
NATURE COMMUNICATIONS (2016)
B cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T cell clonality in chronic lymphocytic leukemia
N. Zaborsky et al.
HAEMATOLOGICA (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
B cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T cell clonality in chronic lymphocytic leukemia
N. Zaborsky et al.
HAEMATOLOGICA (2015)
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
John C. Riches et al.
BLOOD (2013)
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer
Anneke Neumann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy
John C. Riches et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease
Davide Bagnara et al.
BLOOD (2011)
A diversity of beta diversities: straightening up a concept gone awry. Part 1. Defining beta diversity as a function of alpha and gamma diversity
Hanna Tuomisto
ECOGRAPHY (2010)
Antigens in chronic lymphocytic leukemia-Implications for cell origin and leukemogenesis
Anders Rosen et al.
SEMINARS IN CANCER BIOLOGY (2010)
Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing
J. Douglas Freeman et al.
GENOME RESEARCH (2009)
Eμ-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction
Gullu Gorgun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
KDEL-retained antigen in B lymphocytes induces a proinflammatory response: A possible role for endoplasmic reticulum stress in adaptive T cell immunity
Matthew C. Wheeler et al.
JOURNAL OF IMMUNOLOGY (2008)
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma
P Hersey et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Share Paper
